Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Nova Mentis Life Science Corp. C.LIB

Nova Mentis Life Science Corp is a Canadian-based company focused on building and supporting a diversified portfolio of health and wellness businesses. Through its subsidiary, the company is focused on exploring the anti-inflammatory effects of psilocybin in underexplored metabolic indications such as obesity and diabetes and providing a Health Canada Standard Licensed facility focused on the cultivation of AAAA premium, small batch, terpene rich dominant cultivars cured to perfection.


CSE:LIB - Post by User

Comment by TenFingerson Jun 05, 2018 12:40pm
29 Views
Post# 28126738

RE:RE:RE:RE:Pet Trials

RE:RE:RE:RE:Pet TrialsSorry, the wording isn;t the easiest to read between the lines on their news from back in March, 2017.

Is the 160K paid already or upon completion? I bet Ovy knows. :)


TenFingers wrote: So, if I understand this correctly - ESEV is developing specific formulas and testing, under a study funded by LIB, upon successful completion of which LIB owns the patents? Is that correct?

Then LIB pays a percentage of royalties for a number of years.




rcash1 wrote: This is 100% correct and there’s speculation each formulation created by ESEV if for a target illness. ( arthritis, epilepsy, pain management, cancer) ESEV is also working with APH just to give people a idea Of the scope of ESEV . Phase 1 should be complete by now although I’ve yet to confirm that . Remaining warrants at .20 so don’t see this SP getting much lower then these levels. I’m still long for these potentials . The pet market is huge even Canopy has mentioned this a few times lately . Thanks Ovechkin for all the keep up with DD to this board for the newbies . I’ve been busy working nights and 12 hrs a day at that .At a 1000$ a night I Can’t complain though I wanted to make some more $ to increase my position before the next run up  ;)




<< Previous
Bullboard Posts
Next >>